Clinical trial
OptiVol for Precision Medical Management of Heart Failure
NCT04206501 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OptiVol for Precision Medical Management of Heart Failure
- Lead sponsor
- University of Rochester
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 5, 2020
- Completion date
- November 20, 2022
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic and non-ischemic cardiomyopathy